Business article - June 16, 2026
How the Middle East conflict is affecting the life science industry
NLS asked Azza Chammem, Associate Director at Scope Ratings, a European credit rating agency, how the current conflict in the Middle East has affected the life science industry and what the future effects might be.
Global report - June 9, 2026
Sophia Genetics and Memorial Sloan Kettering Cancer Center aim to establish precision medicine hub
SOPHiA Genetics has signed a Memorandum of Understanding (MOU) with Memorial Sloan Kettering Cancer Center (MSK) relating to the formation of a joint venture between the two institutions.
Acquisition - June 8, 2026
Johnson & Johnson to acquire Firefly Bio
Johnson & Johnson has announced it has entered into a definitive agreement to acquire Firefly Bio, biotech company advancing its Firelink degrader antibody conjugate (DAC) platform, for USD 1 billion in cash.
Global report - June 8, 2026
Investigation: The Cancer Calculus
It’s no small irony that one of the world’s most effective cancer drugs also is one of the least accessible.
Acquisition - June 2, 2026
Servier to acquire Edgewise Therapeutics’ Muscular Dystrophy business
French pharma company Servier has entered into an agreement to acquire the muscular dystrophy business of US Edgewise Therapeutics for up to USD 2.65 billion, including upfront payment of USD 1.55 billion as well as up to USD1.1 billion in regulatory and commercial milestone payments.
Financing - May 18, 2026
British AI pioneer Isomorphic Labs secures USD 2.1 billion
The Series B funding will be used to power the company's AI drug design engine, scale its business globally and progress its drug candidate pipeline.
